A Multicentre, Randomised, Double-blind, Placebo-controlled Proof of Concept Study to Compare the Efficacy and Safety of r-hLIF (Emfilermin) for Improving Embryo Implantation Following in Vitro Fertilization (IVF) and Embryo Transfer (ET) in Women With Recurrent Implantation Failure
Latest Information Update: 02 Aug 2024
Price :
$35 *
At a glance
- Drugs Emfilermin (Primary)
- Indications Female infertility
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 05 Nov 2010 New trial record.